中华实用儿科临床杂志2024,Vol.39Issue(4) :271-275.DOI:10.3760/cma.j.cn101070-20231130-00392

儿童抽动障碍药物治疗研究进展

Advances of medicated management for tic disorder in children

王华
中华实用儿科临床杂志2024,Vol.39Issue(4) :271-275.DOI:10.3760/cma.j.cn101070-20231130-00392

儿童抽动障碍药物治疗研究进展

Advances of medicated management for tic disorder in children

王华1
扫码查看

作者信息

  • 1. 中国医科大学盛京医院小儿神经内科,沈阳 110004
  • 折叠

摘要

近年来由于儿童抽动障碍(TD)发病年龄更小、治愈率降低及难治性病例增多,儿童TD的治疗愈发引起人们的关注.现就TD的药物治疗进展,包括a2肾上腺素能激动剂、多巴胺D受体阻滞剂、典型和非典型抗精神病类药物、抗癫痫发作药物、肉毒杆菌毒素A,以及持续至成年期的儿童TD的治疗进行重点介绍,旨在强调儿童TD的正规治疗、足疗程治疗以及个体化治疗的理念.

Abstract

In recent years,more attention has been paid to the treatment of tic disorder(TD)in children owing to a decrease in onset of age and cure rate and an increase in refractory cases.The present article reviews advances in drug therapies for TD,including α2-adrenergic receptors,dopamine receptor D blockers,typical and atypical antipsychotic drugs,antiepileptic drugs,and botulinum toxin type A,as well as the sustainable treatment up to adulthood.It also highlights the regular treatmentfull-course treatment,and individualized treatment for TD in children.

关键词

抽动障碍/儿童/药物治疗

Key words

Tic disorder/Child/Drug therapy

引用本文复制引用

出版年

2024
中华实用儿科临床杂志
中华医学会

中华实用儿科临床杂志

CSTPCD北大核心
影响因子:1.5
ISSN:2095-428X
参考文献量22
段落导航相关论文